Redeye updates its view of Curasight following the Q3 report and recent events in the company.
Redeye updates its estimates following Mestro’s Q3 2023 report, which was weaker in terms of CARR an...
Redeye saw sales and results that were below our expectations.
Adj. EBITDA SEK 1.6m above ABGSCe ACV growth of 1% q-o-q Transformation to subscription model shows ...
B2B fortsätter att leverera Omsättningen i kvartalet uppgick till 48,3 mkr vilket motsvarar en ökni...
Utfall i företrädesemission Bolaget annonserade under gårdagen utfallet i företrädesemissionen som ...
Redeye updates its view on Beyond Frames after the Q3’2023 report.
Redeye updates its view following Fragbite Groups Q3 2023 report, showing a stronger topline than ex...
Redeye comments on Lipigon's Q3 report 2023. The main event since our last comment is the applicatio...
Redeye comments on Enviro’s Q3 report, which was very much on the same theme as we saw in Q2, where ...
STENOCARE announced on November 23rd that the company has signed agreements that will make a new pro...
First Venture (”First Venture” eller ”bolaget”) publicerade den 23 november 2023 bolagets delårsrapp...
Under det tredje kvartalet år 2023 fortsatte Windon Energy Group AB (”Windon” eller ”Bolaget”) uppvi...
Turbulens men förstärkt marginal Nettoomsättningen i Q3 uppgick till EUR 3,7 m (5,8 m), fortsatt pr...
Improved gross margin but weak revenue.
Redeye comments on Beyond Frames Q3 2023 report, showing higher sales than expected but slightly low...
Redeye comments on Fragbite Groups Q3’23 report, showing stronger sales than expected and profitabil...
We hosted CEO Olle Svensk for our Investor Days seminar on 22/11 Continued growth in DTC (~30% y-o-y...
Taaleri hosted its capital markets day yesterday. The event did not offer any large surprises after ...
Redeye updates its view on Flexion Mobile following its Q3 2023 report.
